89
Views
3
CrossRef citations to date
0
Altmetric
Retina

Anterior Migration of Triamcinolone Acetonide after Posterior Subtenon Injection for Macular Edema Predisposes to Intraocular Pressure Elevation

, &
Pages 689-693 | Received 13 Apr 2020, Accepted 15 Sep 2020, Published online: 27 Sep 2020

References

  • Ozdek S, Bahceci UA, Gurelik G, Hasanreisoglu B. Posterior subtenon and intravitreal triamcinolone acetonide for diabetic macular edema. J Diabetes Complications. 2006;20(4):246–51. doi:10.1016/j.jdiacomp.2005.06.015.
  • Ozdek S, Deren YT, Gurelik G, Hasanreisoglu B. Posterior subtenon triamcinolone, intravitreal triamcinolone and grid laser photocoagulation for the treatment of macular edema in branch retinal vein occlusion. Ophthalmic Res. 2008;40(1):26–31. doi:10.1159/000111155.
  • Ozkiris A. Intravitreal triamcinolone acetonide injection for the treatment of posterior uveitis. Ocul Immunol Inflamm. 2006;14(4):233–38. doi:10.1080/09273940600826604.
  • Tsai MJ, Yang CM, Hsieh YT. Posterior subtenon injection of triamcinolone acetonide for pseudophakic cystoid macular oedema. Acta Ophthalmol. 2018;96(7):e891–e893. doi:10.1111/aos.13200.
  • Hirano Y, Ito T, Nozaki M, Yasukawa T, Sakurai E, Yoshida M, Ogura Y. Intraocular pressure elevation following triamcinolone acetonide administration as related to administration routes. Jpn J Ophthalmol. 2009;53(5):519–22. doi:10.1007/s10384-009-0692-5.
  • Hirooka K, Shiraga F, Tanaka S, Baba T, Mandai H. Risk factors for elevated intraocular pressure after trans-tenon retrobulbar injections of triamcinolone. Jpn J Ophthalmol. 2006;50(3):235–38. doi:10.1007/s10384-005-0306-9.
  • Hsieh YT, Yang CM, Chang SH. Bevacizumab and Panretinal photocoagulation protect against ocular hypertension after posterior subtenon injection of triamcinolone acetonide for diabetic macular edema. J Formos Med Assoc. 2017;116(8):599–605. doi:10.1016/j.jfma.2016.09.014.
  • Iwao K, Inatani M, Kawaji T, Koga T, Mawatari Y, Tanihara H. Frequency and risk factors for intraocular pressure elevation after posterior sub-Tenon capsule triamcinolone acetonide injection. J Glaucoma. 2007;16(2):251–56. doi:10.1097/IJG.0b013e31802d696f.
  • Kawamura R, Inoue M, Shinoda H, Shinoda K, Itoh Y, Ishida S, Tsubota K. Incidence of increased intraocular pressure after subtenon injection of triamcinolone acetonide. J Ocul Pharmacol Ther. 2011;27(3):299–304. doi:10.1089/jop.2010.0184.
  • Yamamoto Y, Komatsu T, Koura Y, Nishino K, Fukushima A, Ueno H. Intraocular pressure elevation after intravitreal or posterior sub-Tenon triamcinolone acetonide injection. Can J Ophthalmol. 2008;43(1):42–47. doi:10.3129/i07-186.
  • Tripathi RC, Parapuram SK, Tripathi BJ, Zhong Y, Chalam KV. Corticosteroids and glaucoma risk. Drugs Aging. 1999;15(6):439–50. doi:10.2165/00002512-199915060-00004.
  • Clark AF, Wordinger RJ. The role of steroids in outflow resistance. Exp Eye Res. 2009;88(4):752–59. doi:10.1016/j.exer.2008.10.004.
  • Chan LW, Hsu WC, Hsieh YT. Subtenon triamcinolone acetonide removal for uncontrolled ocular hypertension after posterior subtenon injection of triamcinolone acetonide. J Glaucoma. 2016;25:e268–272.
  • Chawan-Saad J, Wu M, Wu A, Wu L. Corticosteroids for diabetic macular Edema. Taiwan J Ophthalmol. 2019;9(4):233–42. doi:10.4103/tjo.tjo_68_19.
  • Sacconi R, Giuffre C, Corbelli E, Borrelli E, Querques G, Bandello F. Emerging therapies in the management of macular edema: a review. F1000Res. 2019. doi:10.12688/f1000research.19198.1.
  • Otsuka H, Kawano H, Sonoda S, Nakamura M, Sakamoto T. Particle-induced endophthalmitis: possible mechanisms of sterile endophthalmitis after intravitreal triamcinolone. Invest Ophthalmol Vis Sci. 2013;54(3):1758–66. doi:10.1167/iovs.12-11247.
  • Agrawal S, Agrawal J, Agrawal TP. Vitrectomy as a treatment for elevated intraocular pressure following intravitreal injection of triamcinolone acetonide. Am J Ophthalmol. 2004;138(4):679–80. doi:10.1016/j.ajo.2004.05.031.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.